Home LiteratureArticle Details
PMID: 17430994 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Review

Receptor-mediated activation of heterotrimeric G-proteins: current structural insights.

Molecular pharmacology ·Vol. 72 ·No. 2 ·2007-08-00 ·Pages 219-30

Johnston CA, Siderovski DP

Abstract

G-protein-coupled receptors (GPCRs) serve as catalytic activators of heterotrimeric G-proteins (Galphabetagamma) by exchanging GTP for the bound GDP on the Galpha subunit. This guanine nucleotide exchange factor activity of GPCRs is the initial step in the G-protein cycle and determines the onset of various intracellular signaling pathways that govern critical physiological responses to extracellular cues. Although the structural basis for many steps in the G-protein nucleotide cycle have been made clear over the past decade, the precise mechanism for receptor-mediated G-protein activation remains incompletely defined. Given that these receptors have historically represented a set of rich drug targets, a more complete understanding of their mechanism of action should provide further avenues for drug discovery. Several models have been proposed to explain the communication between activated GPCRs and Galphabetagamma leading to the structural changes required for guanine nucleotide exchange. This review is focused on the structural biology of G-protein signal transduction with an emphasis on the current hypotheses regarding Galphabetagamma activation. We highlight several recent results shedding new light on the structural changes in Galpha that may underlie GDP release.

MeSH Terms
Amino Acid Sequence Animals Dimerization Heterotrimeric GTP-Binding Proteins/chemistry,physiology Humans Models, Molecular Molecular Sequence Data Receptors, G-Protein-Coupled/chemistry,physiology Rhodopsin/chemistry Signal Transduction
Chemicals
Receptors, G-Protein-Coupled Rhodopsin Heterotrimeric GTP-Binding Proteins
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Johnston Christopher A
Department of Pharmacology, University of North Carolina at Chapel Hill, CB# 7365, Chapel Hill, NC 27599-7365, USA.
Siderovski David P
Article Info
Journal
Molecular pharmacology
Abbr.
Mol Pharmacol
ISSN
0026-895X
Published
2007-08-00
Epub
2007-00-12
Pages
219-30
Language
English
Region
United States
NLM ID
0035623
Subset
IM
Grants
NIGMS NIH HHS · F32-GM076944 · United States
NIGMS NIH HHS · R01-GM062338 · United States
NIGMS NIH HHS · R01-GM074268 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com